Search

Your search keyword '"Suñol, Mariona"' showing total 249 results

Search Constraints

Start Over You searched for: Author "Suñol, Mariona" Remove constraint Author: "Suñol, Mariona"
249 results on '"Suñol, Mariona"'

Search Results

2. EpiGe: A machine-learning strategy for rapid classification of medulloblastoma using PCR-based methyl-genotyping

3. MIF/CXCR4 signaling axis contributes to survival, invasion, and drug resistance of metastatic neuroblastoma cells in the bone marrow microenvironment

4. SPARC-mediated long-term retention of nab-paclitaxel in pediatric sarcomas

6. Treatment-driven selection of chemoresistant Ewing sarcoma tumors with limited drug distribution

8. A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal/ganglion cell gene expression

10. Immunohistochemical expression of TFF1 is a marker of poor prognosis in retinoblastoma

12. WNT-activated embryonal tumors of the pineal region: ectopic medulloblastomas or a novel pineoblastoma subgroup?

13. The molecular landscape of glioma in patients with Neurofibromatosis 1

15. Immunohistochemical expression of TFF1 is a new prognostic marker in retinoblastoma

18. Immunohistochemical expression of TFF1 is a marker of poor prognosis in retinoblastoma.

20. Supplementary Table S7 from The Genomic Landscape of Pediatric Ewing Sarcoma

21. Supplementary Methods, Figure Legends, Figures S1 - S6, Tables S1, S3 - S6, S8 - S15, S17 from The Genomic Landscape of Pediatric Ewing Sarcoma

22. Data from A Three-Gene Expression Signature Model for Risk Stratification of Patients with Neuroblastoma

23. Data from A Novel Method for Rapid Molecular Subgrouping of Medulloblastoma

24. Supplementary Appendix from A Novel Method for Rapid Molecular Subgrouping of Medulloblastoma

25. Supplementary Table 5 from A Three-Gene Expression Signature Model for Risk Stratification of Patients with Neuroblastoma

26. Supplementary Table 1 from A Three-Gene Expression Signature Model for Risk Stratification of Patients with Neuroblastoma

27. Supplementary Figures 1-11, Tables 2-4 from A Three-Gene Expression Signature Model for Risk Stratification of Patients with Neuroblastoma

28. Supplementary Tables from A Novel Method for Rapid Molecular Subgrouping of Medulloblastoma

29. Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination

31. Follow‐up of intraocular retinoblastoma through the quantitative analysis of conserved nuclear DNA sequences in aqueous humor from patients

34. SPARC-mediated long-term retention of nab-paclitaxel in pediatric sarcomas

37. Identification of immunosuppressive factors in retinoblastoma cell secretomes and aqueous humor from patients

38. AC-265347 Inhibits Neuroblastoma Tumor Growth by Induction of Differentiation without Causing Hypocalcemia

39. Follow‐up of intraocular retinoblastoma through the quantitative analysis of conserved nuclear DNA sequences in aqueous humor from patients.

44. Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors

45. Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors

46. Ectodermal dysplasia-skin fragility syndrome: two new cases with a novel missense mutation

48. GEIS 39: Phase II trial of nabpaclitaxel for the treatment of patient with multiply relapsed/refractory desmoplastic small round cell tumor (DSRCT) and Ewing sarcoma (EwS).

49. Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial ependymoma

50. Prognostic value of patient‐derived xenograft engraftment in pediatric sarcomas

Catalog

Books, media, physical & digital resources